← Back to Patent Explorer
US5688489A Expired / Lapsed US ⏱️ 0.0 years remaining

Non-receptor mediated imaging agents

Assignee: Bracco Imaging SpA
•
Filing: 1995-09-15
•
Granted: 1997-11-18
•
Expires: 2015-09-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Detectably labelled non-receptor mediated cell-associating compounds are provided for use in the diagnostic imaging of target sites in a mammal. Cell-associating compounds may be directly labelled, or labelled via a chelating compound to form a conjugate. Such cell-associating compounds are particularly useful to image target sites such as tumour sites and sites of infection.

Inventors

  • 👤 Susan H. Peers
  • 👤 Anne Goodbody
  • 👤 Alfred Pollak
  • 👤 John Thornback

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 04:30
CPC Classifications
A; A61; A61K; A61K51/00; A61K51/02; A61K51/04; A61K51/08; A61K51/088; C; C07; C07K; C07K14/00; C07K14/001; C07K14/435; C07K14/46; A61K2123/00

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 3 words
The compound, dimethyl-G-S-C(Acm)-βA-βA-βA-G-I-G-K-F-L-H-S-A-G-K-F-G-K-A-F-V-G-E-I-M-K-S.
Claim 2
Dependent Claim 3 words
The compound, dimethyl-G-S-C(Acm)-βA-βA-βA-G-I-G-K-F-L-H-S-A-G-K-F-G-K-A-F-V-G-E-I-M-K-S.
Claim 3
Dependent Claim 41 words
A non-receptor mediated cell-associating compound coupled to a detectable label, wherein said compound is selected from the group consisting of magainin peptides, and functionally equivalent analogues thereof, wherein said label is linked to said compound via a chelator comprising dimethylglycine-serine-cysteine (Acm).
Claim 4
Dependent Claim 41 words
A non-receptor mediated cell-associating compound coupled to a detectable label, wherein said compound is selected from the group consisting of magainin peptides, and functionally equivalent analogues thereof, wherein said label is linked to said compound via a chelator comprising dimethylglycine-serine-cysteine (Acm).
Claim 5
Dependent Claim 38 words
A compound as defined in claim 2, wherein said chelator is linked to said compound via a linker, wherein said linker is selected from the group consisting of glycine-asparagine-glycine, and a linker consisting of from 1-5 β-alanine residues.
Claim 6
Dependent Claim 68 words
A non-receptor mediated cell-associating compound coupled to a detectable label, wherein said compound is selected from the group consisting of magainin peptides, and functionally equivalent analogs thereof, wherein said label is linked to said compound via a chelator, wherein said chelator is linked to said compound via a linker, and said linker is selected from the group consisting of glycine-asparagine-glycine, and a linker consisting of from 1-5β-alanine residues.
Claim 7
Dependent Claim 68 words
A non-receptor mediated cell-associating compound coupled to a detectable label, wherein said compound is selected from the group consisting of magainin peptides, and functionally equivalent analogs thereof, wherein said label is linked to said compound via a chelator, wherein said chelator is linked to said compound via a linker, and said linker is selected from the group consisting of glycine-asparagine-glycine, and a linker consisting of from 1-5β-alanine residues.

References Cited (Backward Citations)

US4810777A Cited
US5091514A Cited
WO1990011770A1 Cited
WO1993003772A1 Cited
WO1993011783A1 Cited
US5491074A Cited
WO1994029727A1 Cited
US5480970A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2000-11-17 2001-05-19 2001-11-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2004-11-17 2005-05-19 2005-11-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2008-11-17 2009-05-19 2009-11-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag